-
公开(公告)号：US08993734B2
公开(公告)日：2015-03-31
申请号：US12789365
申请日：2010-05-27
申请人： Leopold Bruckschwaiger , Sonja Svatos , Julia Nürnberger , Wolfgang Teschner , Harald Arno Butterweck , Hans-Peter Schwarz , Thomas Gundinger , Bernhard Koelbl , Reinhard Grausenburger , Azra Pljevljakovic
发明人： Leopold Bruckschwaiger , Sonja Svatos , Julia Nürnberger , Wolfgang Teschner , Harald Arno Butterweck , Hans-Peter Schwarz , Thomas Gundinger , Bernhard Koelbl , Reinhard Grausenburger , Azra Pljevljakovic
IPC分类号： A23J1/00 , C07K1/00 , C07K14/16 , C07K16/00 , C07K17/00 , C07K1/36 , A61K9/00 , A61K9/08 , A61K35/16 , A61K47/18 , C07K1/30 , C07K16/06 , A61K38/17 , C07K1/14 , C07K1/34 , C07K1/18
CPC分类号： C07K1/36 , A61K9/0019 , A61K9/08 , A61K35/16 , A61K38/1709 , A61K47/183 , C07K1/14 , C07K1/18 , C07K1/30 , C07K1/34 , C07K16/065
摘要： The present invention provides improved methods for the manufacturing of IVIG products. These methods offer various advantages such as reduced loss of IgG during purification and improved quality of final products. In other aspects, the present invention provides aqueous and pharmaceutical compositions suitable for intravenous, subcutaneous, and/or intramuscular administration. In yet other embodiments, the present invention provides methods of treating a disease or condition comprising administration of an IgG composition provided herein.
摘要翻译： 本发明提供了用于制造IVIG产品的改进方法。 这些方法提供各种优点，例如在净化期间减少IgG的损失并提高最终产品的质量。 在其它方面，本发明提供适用于静脉内，皮下和/或肌内给药的水性和药物组合物。 在其它实施方案中，本发明提供了治疗疾病或病症的方法，包括施用本文提供的IgG组合物。
-
公开(公告)号：US20110293598A1
公开(公告)日：2011-12-01
申请号：US13085056
申请日：2011-04-12
申请人： Leopold Bruckschwaiger , Sonja Svatos , Julia Nürnberger , Wolfgang Teschner , Harald Arno Butterweck , Hans-Peter Schwarz , Thomas Gundinger , Bernhard Koelbl , Reinhard Grausenburger , Azra Pljevljakovic
发明人： Leopold Bruckschwaiger , Sonja Svatos , Julia Nürnberger , Wolfgang Teschner , Harald Arno Butterweck , Hans-Peter Schwarz , Thomas Gundinger , Bernhard Koelbl , Reinhard Grausenburger , Azra Pljevljakovic
IPC分类号： A61K39/395 , A61P31/00 , A61P37/00 , C07K16/00 , A61P37/04
摘要： The present invention provides improved methods for the manufacturing of IVIG products. These methods offer various advantages such as reduced loss of IgG during purification and improved quality of final products. In other aspects, the present invention provides aqueous and pharmaceutical compositions suitable for intravenous, subcutaneous, and/or intramuscular administration. In yet other embodiments, the present invention provides methods of treating a disease or condition comprising administration of an IgG composition provided herein.
-
公开(公告)号：US08796430B2
公开(公告)日：2014-08-05
申请号：US13085056
申请日：2011-04-12
申请人： Leopold Bruckschwaiger , Sonja Svatos , Julia Nürnberger , Wolfgang Teschner , Harald Arno Butterweck , Hans-Peter Schwarz , Thomas Gundinger , Bernhard Koelbl , Reinhard Grausenburger , Azra Pljevljakovic
发明人： Leopold Bruckschwaiger , Sonja Svatos , Julia Nürnberger , Wolfgang Teschner , Harald Arno Butterweck , Hans-Peter Schwarz , Thomas Gundinger , Bernhard Koelbl , Reinhard Grausenburger , Azra Pljevljakovic
IPC分类号： A23J1/00 , C07K1/00 , C07K14/16 , C07K16/00 , C07K17/00 , C07K1/14 , C07K1/30 , C07K1/34 , C07K1/18
摘要： The present invention provides improved methods for the manufacturing of IVIG products. These methods offer various advantages such as reduced loss of IgG during purification and improved quality of final products. In other aspects, the present invention provides aqueous and pharmaceutical compositions suitable for intravenous, subcutaneous, and/or intramuscular administration. In yet other embodiments, the present invention provides methods of treating a disease or condition comprising administration of an IgG composition provided herein.
摘要翻译： 本发明提供了用于制造IVIG产品的改进方法。 这些方法提供各种优点，例如在净化期间减少IgG的损失并提高最终产品的质量。 在其它方面，本发明提供适用于静脉内，皮下和/或肌内给药的水性和药物组合物。 在其它实施方案中，本发明提供了治疗疾病或病症的方法，包括施用本文提供的IgG组合物。
-
公开(公告)号：US20110293638A1
公开(公告)日：2011-12-01
申请号：US12789365
申请日：2010-05-27
申请人： Leopold Bruckschwaiger , Sonja Svatos , Julia N+e,uml u+ee rnberger , Wolfgang Teschner , Harald Arno Butterweck , Hans-Peter Schwarz , Thomas Gundinger , Bernhard Koelbl , Reinhard Grausenberger , Azra Pljevljakovic
发明人： Leopold Bruckschwaiger , Sonja Svatos , Julia N+e,uml u+ee rnberger , Wolfgang Teschner , Harald Arno Butterweck , Hans-Peter Schwarz , Thomas Gundinger , Bernhard Koelbl , Reinhard Grausenberger , Azra Pljevljakovic
IPC分类号： A61K39/395 , A61P37/00 , A61P31/00
CPC分类号： C07K1/36 , A61K9/0019 , A61K9/08 , A61K35/16 , A61K38/1709 , A61K47/183 , C07K1/14 , C07K1/18 , C07K1/30 , C07K1/34 , C07K16/065
摘要： The present invention provides improved methods for the manufacturing of IVIG products. These methods offer various advantages such as reduced loss of IgG during purification and improved quality of final products. In other aspects, the present invention provides aqueous and pharmaceutical compositions suitable for intravenous, subcutaneous, and/or intramuscular administration. In yet other embodiments, the present invention provides methods of treating a disease or condition comprising administration of an IgG composition provided herein.
摘要翻译： 本发明提供了用于制造IVIG产品的改进方法。 这些方法提供各种优点，例如在净化期间减少IgG的损失并提高最终产品的质量。 在其它方面，本发明提供适用于静脉内，皮下和/或肌内给药的水性和药物组合物。 在其它实施方案中，本发明提供了治疗疾病或病症的方法，包括施用本文提供的IgG组合物。
-
-
-
搜索结果
4 条记录 (耗时 0.014 秒)
